MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: Risk Capital_Angel, Venture, Sovereign Wealth Investor Companies & Organizations
Keiretsu Forum
Industry: Silicon Valley, California
Amunix Pharmaceuticals
Organization & Developments: Amunix
Parents
Amunix Pharmaceuticals
Children
Amunix has designed the XPAT™ platform using its longstanding and validated XTEN technology as a mask for T cell engagers (TCEs).
Combines TCEs with proprietary protease release sites to selectively unleash the potent activity of TCEs in the tumor by taking advantage of the high protease activity in the tumor microenvironment
Jumps
*Key People: Amunix
Finance & Acquisitions: Amunix